Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy using retroviral vectors

E M Gordon1, W F Anderson

  • 1University of Southern California School of Medicine, Los Angeles.

Current Opinion in Biotechnology
|December 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coupling between spontaneous pupillary fluctuations and brain activity relates to inattentiveness.

The European journal of neuroscience·2016
Same author

Topic: Inguinal Hernia - Post op chronic pain: incidence, evaluation, legal consequences, therapy, follow up.

Hernia : the journal of hernias and abdominal wall surgery·2015
Same author

A CCL24-dependent pathway augments eosinophilic airway inflammation in house dust mite-challenged Cd163(-/-) mice.

Mucosal immunology·2015
Same author

Detrusor myotomy: a 5-year review in unstable and non-compliant bladders.

BJU international·2002
Same author

Preclinical evaluation of the penciclovir analog 9-(4-[(18)F]fluoro-3-hydroxymethylbutyl)guanine for in vivo measurement of suicide gene expression with PET.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2001
Same author

Retroviral vectors bearing IgG-binding motifs for antibody-mediated targeting of vascular endothelial growth factor receptors.

International journal of molecular medicine·2001
Same journal

Microbial C1 assimilation pathways for chemical synthesis: from native metabolism to synthetic design.

Current opinion in biotechnology·2026
Same journal

Medicinal plants fermentation: current knowledge and perspectives.

Current opinion in biotechnology·2026
Same journal

Fermented foods: lessons learned from metagenomics.

Current opinion in biotechnology·2026
Same journal

Microfluidic platforms for the transient transfection of mammalian cells: recent developments and challenges.

Current opinion in biotechnology·2026
Same journal

Harvesting insights from recent advances in yeast genomics for predictable and precision wine fermentation.

Current opinion in biotechnology·2026
Same journal

Minimal enzyme cascades for the aromatic-to-aromatic upgrading of lignin monomers.

Current opinion in biotechnology·2026
See all related articles

Gene therapy utilizes retroviral vectors for genetic disorders like cancer. Technological advancements are making gene therapy more accessible for widespread clinical use.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Medical Science

Background:

  • Gene therapy offers a novel treatment for genetic disorders, including cancer and AIDS.
  • Retroviral vector-mediated gene transfer is a primary method, with over 40 clinical trials underway.
  • Current protocols demand specialized centers for gene therapy administration.

Purpose of the Study:

  • To review the advancements in retroviral vector technology for gene therapy.
  • To highlight improvements in vector production and large-scale cell manufacturing.
  • To discuss the potential for more accessible gene therapy administration.

Main Methods:

  • Review of current retroviral vector technology and clinical applications.
  • Analysis of recent technological improvements in vector production (concentration, lyophilization).

Related Experiment Videos

  • Examination of large-scale production of vector-produced cells for specific cancers like brain cancer.

    • Main Results:

    • Retroviral vectors are extensively studied and approved for numerous clinical trials.
    • Optimized production methods yield high-titer vectors and enable large-scale cell production.
    • Development is ongoing for vectors suitable for direct in-body injection and targeted delivery.

    Conclusions:

    • Technological progress is enhancing the efficiency and scalability of gene therapy.
    • Future developments aim to simplify administration, potentially allowing in-office procedures.
    • These advancements promise to significantly broaden the clinical applications of gene therapy.